UPDATE : Monday, May 25, 2020
상단여백
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
Ildong signs co-promotion contract with GSK Consumer Healthcare by Lee Han-soo 2019-12-03 15:18
Global diabetes group opens 5-day show in Busan by Lee Han-soo 2019-12-03 11:04
라인
LG Chem licenses in US firm’s diagnostic platform tech by Lee Han-soo 2019-12-02 13:42
Syntekabio views industry’s crisis as opportunity by Jeong Sae-im 2019-11-29 17:54
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment by Lee Han-soo 2019-11-29 15:42
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
Hanmi's Chinese partner to start trials for anticancer treatment by Lee Han-soo 2019-11-28 17:38
라인
GI Innovation licenses out immunotherapy drug candidate to Chinese firm by Lee Han-soo 2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit by Lee Han-soo 2019-11-28 15:36
ST Pharm submits IND application for colorectal cancer treatment in US by Lee Han-soo 2019-11-28 14:52
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Experts ascribe excessive diabetes hospitalization to lack of early treatment by Lee Han-soo 2019-11-28 11:26
라인
Bristol-Myers Squibb Korea names new CEO by Lee Han-soo 2019-11-28 11:26
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease by Lee Han-soo 2019-11-27 18:21
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics by Lee Han-soo 2019-11-26 18:48
Amgen releases analysis result showing benefits of LDL-C treatment by Lee Han-soo 2019-11-26 17:05
여백
여백
여백
Back to Top